Catalyst Wire Dossier Catalyst Wire Dossier

CHILDRENS XYZAL ALLERGY

LEVOCETIRIZINE DIHYDROCHLORIDE · Chattem, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CHILDRENS XYZAL ALLERGY, covering 2017-01-31 to 2026-03-05. Get the full timeline:

Most recent: FDA Approved: CHILDRENS XYZAL ALLERGY — Supplemental Application (Chattem, Inc.)

See pricing